Cargando…

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

BACKGROUND: Effective systemic treatments have revolutionized the management of patients with metastatic melanoma, including those with brain metastases. The extent to which these treatments influence disease trajectories close to death is unknown. Therefore, this study aimed to gain insight into pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eggen, Annemarie C., Hospers, Geke A. P., Bosma, Ingeborg, Kramer, Miranda C. A., Reyners, Anna K. L., Jalving, Mathilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897874/ https://www.ncbi.nlm.nih.gov/pubmed/35247992 http://dx.doi.org/10.1186/s12885-022-09316-7

Ejemplares similares

OTHR-01. Unmet clinical needs in patients with brain metastases in the current treatment era
por: Eggen, Annemarie C, et al.
Publicado: (2021)

Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma
por: Eggen, Annemarie C., et al.
Publicado: (2021)

A methodology to systematically analyze the hospital discharge of terminally ill patients
por: Eggen, Annemarie Cécile, et al.
Publicado: (2018)

Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
por: Eggen, Annemarie C, et al.
Publicado: (2021)

Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma
por: Faut, Marloes, et al.
Publicado: (2018)

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
por: Sajan, Abin, et al.
Publicado: (2023)

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
por: Bisschop, Cornelis, et al.
Publicado: (2018)

Currently available treatment options for neuroendocrine liver metastases
por: Machairas, Nikolaos, et al.
Publicado: (2021)

Multimodal treatment options for bilobar colorectal liver metastases
por: Homayounfar, Kia, et al.
Publicado: (2010)

Improving IBD outcomes in the era of many treatment options
por: Kobayashi, Taku, et al.
Publicado: (2023)

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
por: van de Donk, Pim P., et al.
Publicado: (2021)

A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
por: Wind, Thijs T., et al.
Publicado: (2019)

Treatment options for PNET liver metastases: a systematic review
por: Nigri, Giuseppe, et al.
Publicado: (2018)

Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance
por: Doyle, Michelle, et al.
Publicado: (2020)

Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options
por: Morel, Chantal M., et al.
Publicado: (2021)

Analysis of Treatment Option for Synchronous Liver Metastases and Colon Rectal Cancer
por: Coco, Danilo, et al.
Publicado: (2019)

A patient with metastatic melanoma presenting with gastrointestinal perforation after dacarbazine infusion: a case report
por: Oosting, Sjoukje F, et al.
Publicado: (2010)

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
por: van Not, Olivier J., et al.
Publicado: (2023)

Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases
por: de Baère, T., et al.
Publicado: (2015)

New Era: Endoscopic treatment options in obesity–a paradigm shift
por: Glass, Jason, et al.
Publicado: (2019)

Hypoplastic left heart syndrome [HLHS]: treatment options in present era
por: Rai, Vivek, et al.
Publicado: (2018)

Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options
por: Krajnc, Nik, et al.
Publicado: (2021)

Denosumab: a new option in the treatment of bone metastases from urological cancers
por: Yuasa, Takeshi, et al.
Publicado: (2012)

The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases
por: Line, Pål-Dag, et al.
Publicado: (2018)

Ollier Disease: A Case Report and Review of Treatment Options
por: Kramer, Hunter D, et al.
Publicado: (2023)

Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series
por: van Schie, P., et al.
Publicado: (2023)

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
por: Donnem, Tom, et al.
Publicado: (2013)

Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options
por: van Leeuwen, Roelof W. F., et al.
Publicado: (2017)

Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores
por: Broekman, K.E., et al.
Publicado: (2021)

Management of Melanoma Brain Metastases in the Era of Targeted Therapy
por: Shapiro, Daniela Gonsalves, et al.
Publicado: (2011)

Melanoma Brain Metastases in the Era of Target Therapies: An Overview
por: Becco, Paolo, et al.
Publicado: (2020)

Outcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatment
por: Chan, Kun-Ming, et al.
Publicado: (2011)

Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer
por: Broekman, K. Esther, et al.
Publicado: (2020)

Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents
por: Risitano, Antonio M, et al.
Publicado: (2008)

Treatment Equity in the Immunotherapy Era: Options for Patients with Both Autoimmune Disease and GU Cancers
por: Hui, Gavin, et al.
Publicado: (2022)

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
por: Radhakrishnan, Yeshwanter, et al.
Publicado: (2022)

Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era
por: Chen, Xingchen, et al.
Publicado: (2023)

Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
por: Hartz, Ingeborg, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_2g32gueul5t3ejti4qu5af5bum